Respiratory Diseases

Pharma News and Updates for Luye Pharma, AstraZeneca, Oramed, Eisai, AbbVie

Notizia - Recent Pharma, Healthcare and Biotech Happenings

FDA Approves Luye’s Rykindo; EU Approves AstraZeneca’s Tezspire; Oramed Announces Trial Results of ORMD-0801; Eisai and Biogen File Lecanemab in the EU; AbbVie and Anima Biotech Announce Collaboration; AstraZeneca’s Avillion Receives FDA Approval

FDA Approves Luye Pharma’s Rykindo for Schizophrenia Luye Pharma has received its first FDA approval for Rykindo, an injectable formulation of the antipsychotic risperidone administered every two weeks. Rykindo has been approved by the US Food and Drug Administration for the treatment of schizophrenia as well as monotherapy or adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder in adults. The bi-weekly intramuscular shot, which was also approved in China in 2021, will enter a crowded market for long-acting injectable (LAI) schizophrenia therapies in the United States, where it will face stiff competition from drugs that...

Explore More...

What is Driving the Pertussis Treatment Market Forward?

medtech-news-for-baxter-medtronic-atacor-brainq

BrainQ’s EMAGINE Trial; AtaCor’s EV-ICD study; Urotronic’s Optilume Urethral Drug-Coated Balloon approval; Medtronic receives 510(k) clearance; Baxter acquires Hillrom

medtech-news-for-boston-scientific-bd-roche-linus-helioliver

Boston Scientific’s MODULAR CRM System; Restore Medical’s ContraBand clinical trial result; BD acquires Venclose; Roche differentiates mutations in Omicron; Linus’s StrandDx-ASD; HelioLiver launches liquid biopsy test

pharma-news-for-bluebird-bio-fda-twist-bioscience-sosei-heptares

Bluebird bio may get gene therapy approved in the US; Neurocrine pens $2.6B pact with Sosei Heptares; FDA opens clearances for hepatitis C diagnostics; Twist nabs antibody discovery biotech Abveris for $190M

covid-19-and-the-social-determinants-of-health

Social Determinants of Health and their Impact on COVID-19

medtech-news-updtes-updates-for-syntellix-bausch-lomb-movair-cochlear-laborie

Bausch + Lomb’s LuxSmart Intraocular Lenses; Movair’s Luisa Life Supporting Ventilator; Cochlear’s Nucleus and Baha Systems; Laborie Acquires Pelvalon; Know Labs’s SARS-CoV-2 Research; Syntellix’s MAGNEZIX;

recent-pharma-news-and-updates-for-sanofi-marinus-orion-mestag-moderna

Sanofi bets $3.2B on mRNA; Marinus signs $30M deal with Orion; Mestag with $45M seed; Moderna secures fast track designation

chronic-respiratory-disease-crd-prevalence-and-treatment-options

Pfizer hit by DMD delay & halts BCMA trials; Sarepta’s drug shows promise in Phase II; Human organ chips enable COVID-19 drug repurposing; AbCellera takes new antibody into clinic

COVID-19-Vaccines-Hemophilia-B-uniQure-Gene-Therapy-J-J-Covid-Vaccine-Covaxin

Ocugen-Bharat Biotech’s Covaxin Against B.1.617 Corona Variant; uniQure Shares; J&J Covid Vaccine; Sanofi-Moderna COVID Vaccine Deal

Cystic Fibrosis Market | Vertex Pharmaceuticals

Cystic Fibrosis Market: A Rapidly Expanding Playing Field for Mid-Cap Pharma

recent-pharma-biotech-happenings-for-bms-prothena-canon-medical-immunovant

Plaque psoriasis drug outshines in phase III trial; Immunovant announces pause in trial of IMVT-1401; Prothena brings AL amyloidosis drug back; Canon Medical expands its MRI AI programs

$Chronic Refractory Cough Market | Chronic refractory cough Treatment$

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Respiratory Diseases

FDA Approves Luye’s Rykindo; EU Approves AstraZeneca’s Tezspire; Oramed Announces Trial Results of ORMD-0801; Eisai and Biogen File Lecanemab in the EU; AbbVie and Anima Biotech Announce Collaboration; AstraZeneca’s Avillion Receives FDA Approval

What is Driving the Pertussis Treatment Market Forward?

BrainQ’s EMAGINE Trial; AtaCor’s EV-ICD study; Urotronic’s Optilume Urethral Drug-Coated Balloon approval; Medtronic receives 510(k) clearance; Baxter acquires Hillrom

Boston Scientific’s MODULAR CRM System; Restore Medical’s ContraBand clinical trial result; BD acquires Venclose; Roche differentiates mutations in Omicron; Linus’s StrandDx-ASD; HelioLiver launches liquid biopsy test

Bluebird bio may get gene therapy approved in the US; Neurocrine pens $2.6B pact with Sosei Heptares; FDA opens clearances for hepatitis C diagnostics; Twist nabs antibody discovery biotech Abveris for $190M

Social Determinants of Health and their Impact on COVID-19

Bausch + Lomb’s LuxSmart Intraocular Lenses; Movair’s Luisa Life Supporting Ventilator; Cochlear’s Nucleus and Baha Systems; Laborie Acquires Pelvalon; Know Labs’s SARS-CoV-2 Research; Syntellix’s MAGNEZIX;

Sanofi bets $3.2B on mRNA; Marinus signs $30M deal with Orion; Mestag with $45M seed; Moderna secures fast track designation

Alarming Growth of Chronic Respiratory Diseases (CRDs) and Their Prolonged Impact on the Quality of Life

More Views & Analysis

InnoCare’s Trial In China; Sanofi/GSK COVID-19 Vaccine; Apellis’s Empaveli for PNH; LianBio, Landos Collab

Asthma: Rising Prevalence And The Key Challenges In The Management

Abingworth & Alebund’s Finacial Closing; Pfizer/BioNTech COVID-19 Vaccine Expanded Use; Biogen and Capsigen Deal

Pfizer hit by DMD delay & halts BCMA trials; Sarepta’s drug shows promise in Phase II; Human organ chips enable COVID-19 drug repurposing; AbCellera takes new antibody into clinic

Ocugen-Bharat Biotech’s Covaxin Against B.1.617 Corona Variant; uniQure Shares; J&J Covid Vaccine; Sanofi-Moderna COVID Vaccine Deal

Cystic Fibrosis Market: A Rapidly Expanding Playing Field for Mid-Cap Pharma

Plaque psoriasis drug outshines in phase III trial; Immunovant announces pause in trial of IMVT-1401; Prothena brings AL amyloidosis drug back; Canon Medical expands its MRI AI programs

Chronic Refractory Cough Market and the Monopoly of the Over-The-Counter Drugs

Subscribe to our Updates

Daily

Weekly

Monthly